Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema

Short-term results suggest that primary intravitreal Avastin is well tolerated in patients with pseudophakic CME. Treated eyes had a significant improvement in BCVA and decrease in macular thickness by OCT.